Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 4061272)

Published in Oncogene on October 28, 2013

Authors

R Kamekura1, K N Kolegraff1, P Nava2, R S Hilgarth1, M Feng1, C A Parkos1, A Nusrat1

Author Affiliations

1: Epithelial Pathobiology and Mucosal Inflammation Research Unit, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
2: Department of Physiology, Biophysics and Neuroscience, Center for Research and Advanced Studies (CINVESTAV), Mexico DF, Mexico.

Articles citing this

Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol (2015) 0.90

Epithelial adhesion molecules and the regulation of intestinal homeostasis during neutrophil transepithelial migration. Tissue Barriers (2015) 0.87

Desmosome regulation and signaling in disease. Cell Tissue Res (2015) 0.84

Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1. J Virol (2015) 0.82

Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels. Oncotarget (2015) 0.82

Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis. Oncotarget (2015) 0.80

Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion. J Biol Chem (2014) 0.80

Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway. Oncotarget (2016) 0.79

Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget (2016) 0.78

Inflammation-induced desmoglein-2 ectodomain shedding compromises the mucosal barrier. Mol Biol Cell (2015) 0.78

Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma. Virchows Arch (2014) 0.78

Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin Oncol (2016) 0.76

Deposition of microparticles by neutrophils onto inflamed epithelium: a new mechanism to disrupt epithelial intercellular adhesions and promote transepithelial migration. FASEB J (2016) 0.76

A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis (2016) 0.75

c-Src/Cav1-dependent activation of the EGFR by Dsg2. Oncotarget (2016) 0.75

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Oncotarget (2016) 0.75

DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer. Epigenomics (2016) 0.75

Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas. Transl Oncol (2017) 0.75

Articles cited by this

ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer (2005) 16.73

Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res (1989) 4.34

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem (1999) 3.91

Rab11 in recycling endosomes regulates the sorting and basolateral transport of E-cadherin. Mol Biol Cell (2005) 2.74

Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol (2009) 1.73

Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A (1998) 1.54

Structure and function of desmosomes. Int Rev Cytol (2007) 1.51

Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci (2007) 1.39

Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol (2005) 1.39

DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene (2006) 1.31

Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell (2007) 1.27

Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion. Differentiation (2004) 1.17

Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell Adh Migr (2009) 1.15

Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol (2010) 1.10

Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell (2011) 1.07

Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene (2003) 1.05

Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem (2010) 1.01

RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif (2011) 0.96

Assembly of desmosomal cadherins into desmosomes is isoform dependent. J Invest Dermatol (2001) 0.90

Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines. Cell Adh Migr (2011) 0.87

Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice. PLoS One (2012) 0.82

Assessment of desmosomal components (desmoglein 1-3, plakoglobin) in cardia mucosa in relation to gastroesophageal reflux disease and Helicobacter pylori infection. Hum Pathol (2012) 0.79